Highly Leveraged ARCA Pharmaceutical Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
4.84 T
 0.08 
 1.21 
 0.10 
2NVO Novo Nordisk AS
102.79 B
(0.07)
 3.40 
(0.24)
3ABBV AbbVie Inc
67.14 B
 0.15 
 1.36 
 0.20 
4BMY Bristol Myers Squibb
51.2 B
(0.02)
 1.54 
(0.03)
5JNJ Johnson Johnson
36.63 B
 0.09 
 1.20 
 0.11 
6LLY Eli Lilly and
33.64 B
 0.14 
 1.82 
 0.25 
7NVS Novartis AG ADR
31.26 B
 0.03 
 1.30 
 0.04 
8AZN AstraZeneca PLC ADR
30.11 B
 0.17 
 1.23 
 0.21 
9RDY Dr Reddys Laboratories
20.02 B
(0.08)
 1.58 
(0.12)
10VTRS Viatris
18.37 B
(0.19)
 1.33 
(0.25)
11TEVA Teva Pharma Industries
18.08 B
 0.02 
 4.37 
 0.07 
12GSK GlaxoSmithKline PLC ADR
18.02 B
 0.11 
 1.83 
 0.19 
13SNY Sanofi ADR
17.91 B
 0.15 
 1.55 
 0.23 
14OGN Organon Co
8.76 B
 0.01 
 2.72 
 0.02 
15RPRX Royalty Pharma Plc
7.61 B
 0.21 
 1.96 
 0.41 
16ZTS Zoetis Inc
6.74 B
(0.05)
 1.55 
(0.08)
17JAZZ Jazz Pharmaceuticals PLC
5.79 B
 0.21 
 1.50 
 0.31 
18ELAN Elanco Animal Health
5.77 B
(0.12)
 2.09 
(0.25)
19PRGO Perrigo Company PLC
4.07 B
(0.15)
 1.45 
(0.22)
20BHC Bausch Health Companies
2.67 B
(0.04)
 3.18 
(0.12)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.